Catalog #CP10
CJC-1295 No DAC+ Ipamorelin
5 MG + 5 MG
Select Research Tier:
Batch-tested · Research-grade purity · Certificate of Analysis included
Quantity:
Line Total:
$80.00
Technical Research Description
CJC-1295 + Ipamorelin combination research examines the synergistic activation of both GHRH and ghrelin receptor pathways. This combination allows study of amplified growth hormone release while maintaining selectivity and minimizing effects on other hormonal axes.
Simplified Explanation
This combination pairs two growth hormone-releasing peptides that work through different receptors. CJC-1295 mimics the releasing hormone while Ipamorelin mimics ghrelin. Together, they may produce stronger, more consistent growth hormone release. Scientists study their combined effects.
For Research Use Only
DISCLAIMER: This product is sold for research purposes only. Not for human consumption.
By purchasing, you confirm that you are a qualified researcher or represent a research institution, and that this product will be used solely for in-vitro research or lawful scientific study.
Customer Reviews
No reviews yet — be the first to share your experience.
From Our Research Blog
Background reading and laboratory context for CJC-1295 No DAC+ Ipamorelin 5 MG + 5 MG — sourced from our research articles.
research
CJC-1295 No DAC+ Ipamorelin: GH Axis Synergy
A research-first look at how CJC-1295 No DAC and ipamorelin are studied to shape pulsatile GH signaling in preclinical models and …
Aug 31, 2026
research
CJC-1295 (Without DAC): What It Enables in GH Research
A research-first look at CJC-1295 (Without DAC): receptor pharmacology, pulse biology, assay design, and how it differs from DAC v…
Sep 1, 2026
research
Tesamorelin: what it reveals about GH pulse biology
Tesamorelin is a GHRH analog used in growth-axis research. Here's what the literature suggests about pulsatile GH signaling and st…
Aug 26, 2026
research
"WOLVERINE" BPC-157 + TB-500: Combo Rationale
A research-first look at why pairing BPC-157 and TB-500 shows up in repair biology literature, plus practical readouts for lab stu…
Jul 29, 2026
research
AOD-9604 in preclinical metabolism research: what we know
AOD-9604 is a GH-fragment research peptide studied for lipid handling and metabolic signaling. Here's what preclinical data sugges…
Sep 4, 2026
research
Ipamorelin in GH Signaling: What the Data Suggests
Ipamorelin is a ghrelin-receptor agonist used in GH-axis research. Here's what preclinical literature suggests about signaling, se…
Aug 13, 2026
